The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered ...

President Donald Trump announced plans to sign an executive order aimed at significantly reducing U.S. prescription drug ...

Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to ...

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

President Donald Trump has signed an executive order setting a 30-day deadline for drugmakers to electively lower the cost of ...

Merck & Co., Inc. (MRK) is currently at $79.17, up $3.20 or 4.21% --On pace for largest percent increase since March 27, 2024, when it rose 4.96% --Down 40.46% from its all-time closing high of ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Halozyme Therapeutics posts strong Q1 2025 earnings with 35% revenue growth, robust pipeline, and rising royalties.

Trump announces US will no longer subsidize foreign healthcare, seeking price cuts on medicines, impacting global ...

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.